These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8879634

  • 1. Parkinsonism during cyclosporine treatment.
    Wasserstein PH, Honig LS.
    Bone Marrow Transplant; 1996 Sep; 18(3):649-50. PubMed ID: 8879634
    [Abstract] [Full Text] [Related]

  • 2. Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
    Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Sato A, Fujimori K, Satomi S.
    Transplant Proc; 2008 Oct; 40(8):2823-4. PubMed ID: 18929871
    [Abstract] [Full Text] [Related]

  • 3. Postural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathy.
    Paul F, Müller J, Christe W, Steinmüller T, Poewe W, Wissel J.
    Clin Transplant; 2004 Aug; 18(4):429-33. PubMed ID: 15233821
    [Abstract] [Full Text] [Related]

  • 4. [Reversible cortical blindness associated with bilateral occipital lesions caused by cyclosporin A: report of two cases].
    Tamayo JA, Ojea T, Hervás M, León A, Fernández O.
    Neurologia; 1997 Feb; 12(2):89-91. PubMed ID: 9147459
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine-induced retinal toxic blindness.
    López-Jiménez J, Sánchez A, Fernández CS, Gutiérrez C, Herrera P, Odriozola J.
    Bone Marrow Transplant; 1997 Aug; 20(3):243-5. PubMed ID: 9257893
    [Abstract] [Full Text] [Related]

  • 6. Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantation.
    Madan B, Schey SA.
    Bone Marrow Transplant; 1997 Nov; 20(9):793-5. PubMed ID: 9384485
    [Abstract] [Full Text] [Related]

  • 7. Hyperkalemia associated with cyclosporine (CsA) use in bone marrow transplantation.
    Fleming DR, Ouseph R, Herrington J.
    Bone Marrow Transplant; 1997 Feb; 19(3):289-91. PubMed ID: 9028560
    [Abstract] [Full Text] [Related]

  • 8. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y, Zhang Z, Ovadia A, Lapchak PA, Collins F, Hilt D, Lebel C, Kryscio R, Gash DM.
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [Abstract] [Full Text] [Related]

  • 9. Drug-induced parkinsonism after allogeneic bone marrow transplantation.
    Pavletic ZS, Bishop MR, Markopoulou K, Wszolek ZK.
    Bone Marrow Transplant; 1996 Jun; 17(6):1185-7. PubMed ID: 8807135
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A-induced ocular flutter after marrow transplantation.
    Apsner R, Schulenburg A, Steinhoff N, Keil F, Janata K, Kalhs P, Greinix H.
    Bone Marrow Transplant; 1997 Aug; 20(3):255-6. PubMed ID: 9257896
    [Abstract] [Full Text] [Related]

  • 11. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
    Openshaw H, Slatkin NE, Smith E.
    Bone Marrow Transplant; 1997 Mar; 19(5):503-5. PubMed ID: 9052919
    [Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive-associated encephalopathy in bone marrow transplant recipients].
    Ohta K, Yoritaka A, Sakamaki H, Kishida S, Bone Marrow Transplantation Group.
    No To Shinkei; 2004 May; 56(5):395-401. PubMed ID: 15279197
    [Abstract] [Full Text] [Related]

  • 13. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature.
    Drachman BM, DeNofrio D, Acker MA, Galetta S, Loh E.
    J Heart Lung Transplant; 1996 Nov; 15(11):1158-64. PubMed ID: 8956125
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA.
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [Abstract] [Full Text] [Related]

  • 15. [Parkinsonism due to the medication].
    Louter M, Tromp SC.
    Ned Tijdschr Geneeskd; 2009 Nov; 153():A336. PubMed ID: 19900308
    [Abstract] [Full Text] [Related]

  • 16. Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
    Lindner MD, Plone MA, Mullins TD, Winn SR, Chandonait SE, Stott JA, Blaney TJ, Sherman SS, Emerich DF.
    Exp Neurol; 1997 May; 145(1):130-40. PubMed ID: 9184116
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine-associated facial paralysis in a child with renal transplant.
    Ozkaya O, Kalman S, Bakkaloğlu S, Buyan N, Söylemezoğlu O.
    Pediatr Nephrol; 2002 Jul; 17(7):544-6. PubMed ID: 12172772
    [Abstract] [Full Text] [Related]

  • 18. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.
    Steg RE, Kessinger A, Wszolek ZK.
    Bone Marrow Transplant; 1999 May; 23(9):959-62. PubMed ID: 10338054
    [Abstract] [Full Text] [Related]

  • 19. Reversible Parkinsonism after chronic cyclosporin treatment in renal transplantation.
    Ling H, Bhidayasiri R.
    Mov Disord; 2009 Sep 15; 24(12):1848-9. PubMed ID: 19606490
    [No Abstract] [Full Text] [Related]

  • 20. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J, Johnson E, Goldman N, Devereux L, Grana G, Hageboutros A, Fernandez E, Constantinou C, Harrer W, Viner E, Goldberg J.
    Bone Marrow Transplant; 1997 Feb 15; 19(3):221-6. PubMed ID: 9028549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.